Glaukos EPS - Earnings per Share 2014-2024 | GKOS

Glaukos annual and quarterly earnings per share history from 2014 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Glaukos EPS for the quarter ending September 30, 2024 was $-0.39, a 38.1% decline year-over-year.
  • Glaukos EPS for the twelve months ending September 30, 2024 was $-2.96, a 10.04% increase year-over-year.
  • Glaukos 2023 annual EPS was $-2.78, a 33.01% increase from 2022.
  • Glaukos 2022 annual EPS was $-2.09, a 95.33% increase from 2021.
  • Glaukos 2021 annual EPS was $-1.07, a 60.37% decline from 2020.
Glaukos Annual EPS
2023 $-2.78
2022 $-2.09
2021 $-1.07
2020 $-2.70
2019 $0.37
2018 $-0.37
2017 $0.00
2016 $0.12
2015 $-2.13
2014 $-5.29
2013 $-6.21
Glaukos Quarterly EPS
2024-09-30 $-0.39
2024-06-30 $-1.00
2024-03-31 $-0.82
2023-12-31 $-0.75
2023-09-30 $-0.63
2023-06-30 $-0.68
2023-03-31 $-0.72
2022-12-31 $-0.66
2022-09-30 $-0.58
2022-06-30 $-0.96
2022-03-31 $0.11
2021-12-31 $-0.46
2021-09-30 $0.13
2021-06-30 $-0.38
2021-03-31 $-0.36
2020-12-31 $-0.21
2020-09-30 $-0.35
2020-06-30 $-0.90
2020-03-31 $-1.24
2019-12-31 $0.95
2019-09-30 $-0.37
2019-06-30 $-0.17
2019-03-31 $-0.04
2018-12-31 $0.05
2018-09-30 $-0.19
2018-06-30 $-0.15
2018-03-31 $-0.08
2017-12-31 $0.04
2017-09-30 $0.04
2017-06-30 $-0.10
2017-03-31 $0.02
2016-12-31 $0.00
2016-09-30 $0.03
2016-06-30 $0.06
2016-03-31 $0.03
2015-12-31 $9.30
2015-09-30 $-0.07
2015-06-30 $-10.96
2015-03-31 $-0.40
2014-12-31 $-1.94
2014-09-30 $-0.64
2014-06-30 $-0.90
2014-03-31 $-1.83
2013-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.499B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.416B 24.94
Intuitive Surgical (ISRG) United States $192.946B 100.88
Alcon (ALC) Switzerland $43.080B 28.83
Edwards Lifesciences (EW) United States $41.404B 26.29
IQVIA Holdings (IQV) United States $36.405B 20.06
IDEXX Laboratories (IDXX) United States $35.383B 41.67
DexCom (DXCM) United States $31.603B 47.59
Waters (WAT) United States $22.979B 33.98
STERIS (STE) Ireland $21.385B 24.62
SONOVA HOLDING (SONVY) Switzerland $19.978B 0.00
Hologic (HOLX) United States $17.581B 18.99
Fresenius Medical Care AG KGaA (FMS) Germany $13.691B 14.05
Sysmex ADR (SSMXY) Japan $13.362B 41.90
Globus Medical (GMED) United States $11.588B 29.34
Penumbra (PEN) United States $9.412B 92.19
Masimo (MASI) United States $9.326B 45.13
Teleflex (TFX) United States $8.737B 13.94
PROCEPT BioRobotics (PRCT) United States $5.035B 0.00
Integer Holdings (ITGR) United States $4.735B 26.84
Veracyte (VCYT) United States $3.384B 101.54
Inari Medical (NARI) United States $3.018B 0.00
LivaNova (LIVN) United Kingdom $2.803B 16.18
Nihon Kohden (NHNKY) Japan $2.421B 18.39
TransMedics (TMDX) United States $2.398B 76.00
Tandem Diabetes Care (TNDM) United States $2.192B 0.00
Elekta AB (EKTAY) Sweden $2.121B 19.07
Integra LifeSciences Holdings (IART) United States $1.901B 9.93
RxSight (RXST) United States $1.756B 0.00
Alphatec Holdings (ATEC) United States $1.418B 0.00
Pulse Biosciences (PLSE) United States $1.248B 0.00
Artivion (AORT) United States $1.244B 82.44
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.875B 14.87
Paragon 28 (FNA) United States $0.856B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.739B 0.00
IRadimed (IRMD) United States $0.680B 36.74
Mesa Laboratories (MLAB) United States $0.668B 15.75
AxoGen (AXGN) United States $0.635B 0.00
OrthoPediatrics (KIDS) United States $0.634B 0.00
SiBone (SIBN) United States $0.546B 0.00
Treace Medical Concepts (TMCI) United States $0.533B 0.00
Semler Scientific (SMLR) United States $0.527B 31.04
Pacific Biosciences Of California (PACB) United States $0.501B 0.00
Tactile Systems Technology (TCMD) United States $0.453B 24.53
Delcath Systems (DCTH) United States $0.379B 0.00
CVRx (CVRX) United States $0.365B 0.00
NeuroPace (NPCE) United States $0.356B 0.00
ClearPoint Neuro (CLPT) United States $0.331B 0.00
AngioDynamics (ANGO) United States $0.289B 0.00
Inogen (INGN) United States $0.237B 0.00
Accuray (ARAY) United States $0.211B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Sight Sciences (SGHT) United States $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.160B 0.00
Atossa Genetics (ATOS) United States $0.155B 0.00
Sensus Healthcare (SRTS) United States $0.141B 15.05
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.092B 0.00
EDAP TMS S.A (EDAP) France $0.091B 0.00
LENSAR (LNSR) United States $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.088B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Covalon Technologies (CVALF) Canada $0.074B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Accelerate Diagnostics (AXDX) United States $0.039B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Biosig Technologies (BSGM) United States $0.029B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.013B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00